Abstract:Question What safety and postoperative outcomes are associated with transoral surgery in older adult patients (age ≥70 years) with oropharyngeal squamous cell carcinoma? Findings In this cohort study of 10 430 patients with oropharyngeal squamous cell carcinoma, including 1808 patients aged at least 70 years, no clinically meaningful differences were found in terms of postoperative mortality, hospitalization time, unplanned readmissions, or delay in treatment delivery among older patients compared with younger patients. Older patients were less likely to undergo adjuvant radiotherapy and chemotherapy. Meaning These findings suggest that transoral surgery can be safely performed in older patients, with postoperative outcomes comparable with their younger counterparts. Importance Transoral surgery (TOS) has become the primary surgical treatment for oropharyngeal squamous cell carcinoma (OPSCC). However, despite the increasing incidence of OPSCC in older patients, data regarding the safety and postoperative outcomes of TOS in this subgroup are lacking. Objective This study aimed to evaluate the safety and postoperative outcomes of TOS in patients with OPSCC aged 70 years or older compared with younger individuals. Design, Setting, and Participants This retrospective cohort study included patients with microscopic diagnostic confirmation of invasive OPSCC diagnosed between 2010 and 2021. Data were obtained from the US National Cancer Database. Data were analyzed in March 2024. Exposure Minimally invasive TOS not converted to an open approach. Main Outcomes and Measures Multivariable logistic and linear regression models were constructed to compare postoperative outcomes, adjusting for baseline patient and tumor characteristics. The results are reported as odds ratios (ORs) or mean differences with corresponding 95% CI, as appropriate. Results A total of 10 430 patients (mean [SD] age, 60.7 [9.6] years; 8744 [83.8%] male) were included, with 1808 patients (17.3%) aged at least 70 years. No clinically meaningful difference was observed in terms of postoperative mortality at 30 days (adjusted OR, 1.24; 95% CI, 0.65-2.33) or 90 days (adjusted OR, 1.11; 95% CI, 0.65-1.87). Patients aged 70 years or older were less likely to undergo adjuvant radiotherapy (adjusted OR, 0.69; 95% CI, 0.57-0.83) and chemotherapy (adjusted OR, 0.63; 95% CI, 0.51-0.77). In addition, the adjuvant treatment was more frequently not administered in the older population due to patient refusal or comorbidities, despite being clinically indicated (radiotherapy: adjusted OR, 1.36; 95% CI, 1.05-1.77; chemotherapy: adjusted OR, 1.70; 95% CI, 1.17-2.45). No meaningful differences were observed regarding the remaining study outcomes, apart from a slightly longer hospitalization time for older patients, with an adjusted mean difference of 0.39 (95% CI, 0.05-0.74) days. Conclusions and Relevance Findings from this study suggest that age was not independently associated with postoperative mortality in older patients undergoing TOS for OPSCC. However, older patients less frequently received adjuvant radiotherapy and chemotherapy compared with younger patients, and future studies should be conducted to examine the impact on long-term survival.

Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly

Correlation Study Between Advanced Age and Inferior Prognosis in Stage Ⅱ Colorectal Cancer Patients

Impact of age on elderly patients with oral cancer

Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes

Changing Trends in Gastric and Colorectal Cancer among Surgical Patients over 85 Years Old: A Multicenter Retrospective Study, 2001–2021

VP177 Older People With Cancer: To Treat Or Not To Treat With Chemotherapy?

Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland

Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study

Safety and Postoperative Outcomes of Transoral Surgery for Oropharyngeal Carcinoma in Older Adults

Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center

Oral cancer in young adults: should we approach these patients differently?

Factors to consider for surgical in elderly patients with oral cancer

Treatment strategies for patients over 80 years of age with oral squamous cell carcinoma

Impact of Age Stratification on the Clinicopathological Characteristics and Survival Outcomes on Stage IV Oral Tongue Squamous Cell Carcinomas

Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database

Esophageal Cancer in Elderly Patients: a Population-Based Study

Surgical Modality For Stage Ia Non-Small Cell Lung Cancer Among The Elderly: Analysis Of The Surveillance, Epidemiology, And End Results Database

Patient and Physician Decision Styles and Breast Cancer Chemotherapy Use in Older Women: Cancer and Leukemia Group B Protocol 369901

Effects of Surgery on Survival of Patients Aged 75 Years or Older with Oral Tongue Squamous Cell Carcinomas.

Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study

Geographic differences in therapy for stage I non-small-cell lung cancer in older adults